Neogen Chemicals Limited reported a standalone net profit of ₹19.4 crore for the quarter ended June 30, 2026 (Q1FY27), marking a 37% year-on-year increase from ₹14.2 crore in Q1FY26. Revenue from operations rose 37% to ₹252.3 crore, up from ₹184.6 crore in the corresponding prior period, reflecting continued operational recovery following the March 2025 fire incident at its Dahej SEZ plant. Consolidated net profit grew 67% to ₹17.1 crore, while consolidated revenue increased 34% to ₹250.3 crore.

The Board of Directors, meeting on July 24, 2026, approved the unaudited financial results reviewed by statutory auditors Chandabhoy & Jassoobhoy. Management also granted in-principle approval to raise funds of up to ₹600 crore through equity shares, qualified institutional placements (QIP), or other eligible securities, subject to shareholder and regulatory approvals. Additionally, the Board appointed CNK & Associates as the internal auditor for FY2026-27 and scheduled the 37th Annual General Meeting for August 21, 2026.

Financial Performance

Standalone EBITDA expanded to ₹48.2 crore from ₹34.7 crore in Q1FY26, representing a 39% growth. EBITDA margins improved by 30 basis points to 19.1%, compared to 18.8% in the prior year. Profit before tax rose 37% to ₹26.1 crore, with margins stabilizing at 10.4%. Finance costs increased to ₹23.1 crore from ₹14.0 crore year-on-year, partly offset by higher revenue growth. Consolidated EBITDA margins stood at 19.3%, compared to 16.9% in FY26. The company’s debt-equity ratio improved to 0.68 times from 0.79 times at the end of FY25, indicating a strengthening balance sheet.

Insurance Claim Recovery

The company continues to recover from the fire incident on March 5, 2025, which caused a recognized loss of ₹348.16 crore. As of June 30, 2026, Neogen Chemicals had received ₹140.00 crore as on-account payments and realized ₹9.38 crore from scrap sales. An additional ₹15.00 crore was received post-quarter-end, reducing the outstanding insurance claim receivable to ₹186.63 crore. Management maintains that the remaining claim is fully recoverable.

Expansion Initiatives and Strategic Outlook

Neogen Ionics, the wholly owned subsidiary, is advancing its manufacturing setup for lithium-ion battery materials. The company has acquired 264,285 m² of land at Pakhajan, Dahej PCPIR, for a new site planned to come online in FY27. This facility aims to produce 30,000 MT of electrolyte and 3,000 MT of lithium electrolyte salts and additives. Combined with existing capacities at Dahej SEZ, the total planned capacity reaches 32,000 MT for electrolytes and 5,500 MT for salts. The replacement plant for the fire-affected Dahej SEZ unit is expected to be operational by Q2FY27.

Crisil Ratings Limited downgraded the company’s long-term rating to 'Crisil A-/Negative' from 'Crisil A/Negative' on July 17, 2026, leading to a coupon rate increase on its ₹200 crore NCDs from 10.50% to 11.00% per annum. The record date for determining eligibility for remote e-voting and the final dividend for FY25 is set for August 13, 2026. The Register of Members will remain closed from August 14, 2026, to August 21, 2026.

Neogen Chemicals Limited reported a standalone net profit of ₹19.44 crore for the quarter ended June 30, 2026, marking a 36.6% increase from ₹14.23 crore in the corresponding period of the previous year. Revenue from operations rose to ₹252.28 crore from ₹184.58 crore, driven by higher material consumption and inventory adjustments. The Board also granted in-principle approval to raise up to ₹600 crore through equity or debt instruments, signaling strategic capital deployment plans despite a recent credit rating downgrade by Crisil Ratings Limited.

The financial results were approved by the Board at its meeting held on July 24, 2026, and reviewed by statutory auditors Chandabhoy & Jassoobhoy. The company confirmed no deviation in the utilization of funds raised through its preferential issue of equity shares earlier in the year. Additionally, the Board appointed CNK & Associates as the internal auditor for FY27 and set August 13, 2026, as the record date for determining eligibility for remote e-voting and final dividend entitlements at the upcoming 37th Annual General Meeting.

Financial Performance Highlights

On a consolidated basis, net profit stood at ₹17.11 crore against ₹10.26 crore in Q1FY25. Consolidated revenue from operations increased to ₹250.29 crore from ₹186.73 crore. The operating margin improved to 19.35% from 15.96%, reflecting better cost management and operational efficiency post-recovery from the March 2025 fire incident at its Dahej SEZ plant.

Capital Structure and Rating Update

Crisil Ratings Limited downgraded Neogen Chemicals’ long-term rating from 'A/Negative' to 'A-/Negative' and short-term rating from 'A1' to 'A2' on July 17, 2026. Consequently, the coupon rate on its outstanding ₹200 crore Non-Convertible Debentures (NCDs) increased from 10.50% per annum to 11.00% per annum effective immediately. Despite the downgrade, the security coverage ratio for the NCDs remained robust at 2.27 times as of June 30, 2026.

The Board authorized raising funds up to ₹600 crore in Indian or foreign currency via Qualified Institutional Placements (QIP), preferential allotment, or other eligible securities. This move aims to strengthen the balance sheet and support growth initiatives across its specialty chemicals and battery chemicals segments.

Insurance Claim Recovery Status

The company continues to recover from the fire incident at its Dahej plant on March 5, 2025. As of June 30, 2026, Neogen Chemicals had received ₹149.38 crore towards insurance claims and scrap sales against a recognized loss of ₹348.16 crore. An additional ₹15 crore was received subsequent to the quarter-end, reducing the outstanding claim receivable to ₹171.63 crore. Management maintains that the remaining balance is fully recoverable.

What the Numbers Show

The divergence between standalone and consolidated margins highlights the impact of inter-segment transactions and subsidiary performance. While standalone operating margins expanded by 84 basis points to 19.09%, consolidated margins saw a sharper improvement to 19.35% from 15.96%. This suggests that subsidiaries are contributing more efficiently to the group’s overall profitability. However, the rising finance costs—up to ₹23.10 crore from ₹14.03 crore year-on-year—indicate increased leverage, partly due to the new NCD issuance. Investors should monitor whether the planned ₹600 crore fund raise will be deployed to reduce interest burden or expand capacity, given the recent rating downgrade.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE136S01016/41e7ef07-3010-4812-9731-b7fd182a208b.pdf